Fractyl Health Insider Trades
NASDAQ: GUTSHealth CareMedical/Dental InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 7 · $187.32K
- Sales
- 0 · $0
- Shares bought / sold
- 246.43K / 0
- Net activity
- Net buying $187,316
Fractyl Health insider activity
Over the last 12 months, Fractyl Health insiders reported 7 transactions on SEC Form 4: 7 open-market purchases and 0 sales. Insiders bought $187,316 and sold $0 worth of stock, for net insider buying of $187,316. The most recent filing shows BRADLEY WILLIAM (Director) buying 64,516 shares at $0.6185 on Sep 14, 2026.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put GUTS's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
GUTS insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 14, 2026 | BRADLEY WILLIAMDirector | Buy | 64,516 | $39.90K | Form 4 |
| Jun 12, 2026 | Royan AjayDirector | Buy | 23,000 | $19.60K | Form 4 |
| Jun 10, 2026 | Rajagopalan HarithChief Executive Officer | Buy | 25,000 | $18.25K | Form 4 |
| Jun 10, 2026 | Sheffield IanDirector | Buy | 35,000 | $25.53K | Form 4 |
| Jun 10, 2026 | BRADLEY WILLIAMDirector | Buy | 68,493 | $50.33K | Form 4 |
| Jun 8, 2026 | Smith Weber LaraChief Financial Officer | Buy | 20,000 | $13.71K | Form 4 |
| Dec 4, 2025 | Rajagopalan HarithChief Executive Officer | Buy | 10,416 | $20.00K | Form 4 |
| Mar 14, 2025 | Royan AjayDirector | Buy | 17,901 | $22.98K | Form 4 |
| Mar 14, 2025 | Barnes Kelly AnnDirector | Buy | 31,000 | $40.21K | Form 4 |
| Mar 13, 2025 | Conaway SamuelDirector | Buy | 8,550 | $9.96K | Form 4 |
| Mar 13, 2025 | BRADLEY WILLIAMDirector | Buy | 16,129 | $20.36K | Form 4 |
| Mar 13, 2025 | SCHULMAN AMY WDirector | Buy | 8,550 | $9.96K | Form 4 |
| Jan 31, 2025 | Caplan Jay DavidPresident, Chief Product Off. | Sale | 22,346 | $40.46K | Form 4 |
| Jan 31, 2025 | Caplan Jay DavidPresident, Chief Product Off. | Option exercise | 22,346 | $37.99K | Form 4 |
| Jan 31, 2025 | Rajagopalan HarithChief Executive Officer | Sale | 90,972 | $165.21K | Form 4 |
| Jan 31, 2025 | Rajagopalan HarithChief Executive Officer | Option exercise | 90,972 | $154.65K | Form 4 |
| Jan 30, 2025 | Caplan Jay DavidPresident, Chief Product Off. | Sale | 21,472 | $41.80K | Form 4 |
| Jan 30, 2025 | Caplan Jay DavidPresident, Chief Product Off. | Option exercise | 21,472 | $36.50K | Form 4 |
| Jan 30, 2025 | Rajagopalan HarithChief Executive Officer | Sale | 20,948 | $40.80K | Form 4 |
| Jan 30, 2025 | Rajagopalan HarithChief Executive Officer | Option exercise | 20,948 | $35.61K | Form 4 |
| Nov 11, 2024 | Rajagopalan HarithChief Executive Officer | Sale | 96,517 | $238.36K | Form 4 |
| Nov 10, 2024 | Rajagopalan HarithChief Executive Officer | Option exercise | 216,924 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4